COM:ARCUSBIO
Arcus Biosciences
- Stock
Last Close
14.98
26/07 20:00
Market Cap
1.27B
Beta: -
Volume Today
433.94K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|
asset turnover | 0.01 - | 0.03 309.59% | 0.07 143.07% | 0.10 35.91% | 0.24 139.63% | 0.08 65.38% | 0.11 28.31% | ||
cash conversion cycle | -256.79 - | ||||||||
cash per share | 4.03 - | 4.13 2.53% | 7.41 79.47% | 4.30 42.03% | 13.30 209.52% | 7.21 45.81% | 18.42 155.61% | 10.26 44.31% | |
company equity multiplier | 1.10 - | 1.24 12.24% | 1.17 5.48% | 1.24 5.94% | 1.54 24.02% | 1.89 23.05% | 2.05 8.21% | 2.37 15.78% | |
days of inventory outstanding | |||||||||
days of payables outstanding | 387.81 - | ||||||||
days of sales outstanding | 6.46 - | 3.63 43.84% | 3.21 11.44% | 8.00 148.92% | 711.94 8,804.54% | 140.13 80.32% | 131.03 6.50% | ||
dividend yield | |||||||||
ebit per revenue | -37.82 - | -6.57 82.64% | -5.91 9.95% | -1.60 72.90% | 0.14 108.84% | -2.50 1,864.50% | -2.91 16.24% | ||
ebt per ebit | 0.99 - | 0.99 0.50% | 0.90 8.99% | 0.95 5.63% | 0.99 3.56% | 1.01 1.86% | 0.95 5.69% | 0.89 6.81% | |
effective tax rate | -0.11 - | 0.10 197.62% | 0.05 51.45% | 0.03 33.98% | -0.00 111.32% | -0.02 430.23% | |||
enterprise value multiple | -20.88 - | -12.29 41.13% | -5.38 56.24% | -4.34 19.40% | -10.13 133.54% | 50.52 598.78% | -3.51 106.95% | -4.46 26.97% | |
fixed asset turnover | 0.13 - | 0.75 497.70% | 1.61 113.78% | 3.29 104.41% | 2.79 15.22% | 3.20 14.85% | 2.29 28.31% | ||
free cash flow per share | -0.69 - | -0.72 3.52% | -1.35 87.91% | -1.72 27.41% | 1.97 214.69% | -4.07 306.44% | 7.78 290.91% | -4.46 157.35% | |
gross profit margin | 1 - | 1 0% | 1 0% | 1 0% | 1 0% | 1 0% | 0.86 13.68% | ||
interest coverage | -11.15 - | 208.65 - | -140 167.10% | -170 21.43% | |||||
inventory turnover | |||||||||
long term debt to capitalization | 0.03 - | 0.12 314.12% | |||||||
net income per ebt | 1 - | 1 0% | 1 0% | 0.90 10.36% | 0.95 5.95% | 0.97 1.80% | 1.00 3.82% | 1.02 1.61% | |
net profit margin | -37.57 - | -5.94 84.20% | -5.06 14.74% | -1.51 70.27% | 0.14 109.17% | -2.38 1,827.74% | -2.62 10.07% | ||
operating cash flow per share | -0.53 - | -0.59 11.72% | -1.24 110.89% | -1.68 34.96% | 2.03 221.03% | -3.70 282.22% | 7.99 316.27% | -4.14 151.72% | |
operating cycle | 131.03 - | ||||||||
operating profit margin | -37.82 - | -6.57 82.64% | -5.91 9.95% | -1.60 72.90% | 0.14 108.84% | -2.50 1,864.50% | -2.91 16.24% | ||
payables turnover | 0.94 - | ||||||||
pretax profit margin | -37.57 - | -5.94 84.20% | -5.65 4.88% | -1.58 71.94% | 0.14 109.00% | -2.38 1,764.10% | -2.57 8.32% | ||
price fair value | 4.20 - | 4.70 12.01% | 1.59 66.24% | 2.70 70.24% | 2.83 4.83% | 3.33 17.68% | 1.72 48.26% | 3.06 77.40% | |
receivables turnover | 56.52 - | 100.64 78.06% | 113.64 12.92% | 45.65 59.83% | 0.51 98.88% | 2.60 408.04% | 2.79 6.95% | ||
return on assets | -0.16 - | -0.28 70.12% | -0.18 35.27% | -0.37 107.24% | -0.15 59.59% | 0.03 121.97% | -0.20 698.17% | -0.28 41.23% | |
return on capital employed | -0.17 - | -0.30 72.22% | -0.21 29.27% | -0.49 131.25% | -0.19 61.17% | 0.04 119.93% | -0.24 738.83% | -0.37 53.55% | |
return on equity | -0.18 - | -0.34 90.94% | -0.21 38.81% | -0.46 119.55% | -0.23 49.88% | 0.06 127.03% | -0.41 747.28% | -0.66 63.51% | |
total debt to capitalization | 0.02 - | 0.02 25.10% | 0.05 119.74% | 0.08 43.85% | 0.17 113.40% | 0.02 - |
All numbers in (except ratios and percentages)